Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of selonsertib in cardiovascular disease (Japan)
jRCT2080224828Phase 2Completed
- Start
- Aug 2019
- Modality
- Small Molecules
01
Overview
Phase 2 trial of selonsertib. Started Aug 2019; status: completed.
02
Drugs
selonsertib
Beyond the preview
Go deeper on jRCT2080224828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224828.